Why do some lung cancer patients receive no anticancer treatment?

Journal of Thoracic Oncology

Volumn 5, Issue 7, 2010, Pages 1025-1032

  Vinod, Shalini K ^a,b   Sidhom, Mark A ^a   Gabriel, Gabriel S ^b   Lee, Mark T ^a   Delaney, Geoff P ^a  

^a Liverpool Hospital   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Chemotherapy; Lung neoplasms; Patterns of care; Radiotherapy; Treatment utilization

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COMORBIDITY; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADENOCARCINOMA; AUSTRALIA; CANCER STAGING; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; COMPLICATION; DECISION MAKING; IRELAND; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PATHOLOGY; PATIENT PREFERENCE; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; AUSTRALIA; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; DECISION MAKING; FEMALE; HUMANS; IRELAND; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SQUAMOUS CELL; PATIENT PREFERENCE; PROSPECTIVE STUDIES; SCOTLAND; SMALL CELL LUNG CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 77954425693     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181da85e4     Document Type: Article

References (42)

1. Tracey E, Alam N, Chen W, et al. Cancer in New South Wales: Incidence and Mortality 2006. Sydney: Cancer Institute NSW, 2008.
2. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672-1694.
3. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Intl J Cancer 1999;83:18-29.
4. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 29094960)
5. Fry WA, Phillips JL, Menck HR. Ten-year survey of lung cancer treatment and survival in hospitals in the United States. Cancer 1999; 86:1867-1876.
6. Cartman ML, Hatfield AC, Muers MF, et al. Lung cancer: district active treatment rates affect survival. J Epidemiol Community Health 2002;56: 424-429. (Pubitemid 34538994)
7. Vinod SK, O'Connell D, Simonella L, et al. Gaps in optimal care for lung cancer. J Thorac Oncol 2008;3:871-879.
8. Richardson GE, Thursfield VJ, Giles GG. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Med J Aust 2000;172:321-324.
9. Erridge SC, Murray B, Price A, et al. Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol 2008; 3:491-498. (Pubitemid 351630276)
10. South Australian Cancer Registry. Epidemiology of cancer in South Australia. South Australian Cancer Registry; Cancer Series 2000. Report No. 22.
11. Mahmud SM, Reilly M, Comber H. Patterns of initial management of lung cancer in the Republic of Ireland. Lung Cancer 2003;41:57-64.
12. Stevens W, Stevens G, Kolbe J, et al. Lung cancer in New Zealand: patterns of secondary care and implications for survival. J Thorac Oncol 2007;2:481-493. (Pubitemid 47189283)
13. Simonella L, O'Connell D, Vinod SK, et al. No improvement in lung cancer care: the management of lung cancer in 1996 and 2002 in New South Wales, Australia. Int Med J 2009;39:453-458.
14. Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 1995;13:235-252. (Pubitemid 26022990)
15. Lopez-Encuentra A. Comorbidity in operable lung cancer: a multicenter descriptive study on 2992 patients. Lung Cancer 2002;35:263-269. (Pubitemid 34158659)
16. Janssen-Heijnen MLG, Schipper RM, Razenberg PPA, et al. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998;21:105-113.
17. Farjah F, Wood DE, Yanez D III, et al. Temporal trends in the management of potentially resectable lung cancer. Ann Thorac Surg 2008;85:1850-1855. (Pubitemid 351685592)
18. MacKillop WJ, Ward WJ, O'Sullivan B. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer. Br J Cancer 1986;54:661-667. (Pubitemid 17182697)
19. Palmer MJ, O'Sullivan B, Steele R, et al. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study. Radiother Oncol 1990;19:17-28. (Pubitemid 20264686)
20. Cancer Council Australia. Clinical Practice Guidelines for the prevention, diagnosis and management of lung cancer. Cancer Council Australia, 2004. Available at: http://www.nhmrc.gov.au/publications/subjects/cancer.htm. Accessed September 20, 2009.
21. American College of Chest Physicians; Health and Science Policy Committee. Diagnosis and management of lung cancer: ACCP evidence-based guidelines. American College of Chest Physicians. Chest 2003; 123:1S-337S.
22. National Collaborating Centre for Acute Care. The diagnosis and treatment of lung cancer. London: National Collaborating Centre for Acute Care, 2005. Available at: http://www.rcseng.ac.uk/publications/docs/year.html. Accessed September 20, 2009.
23. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer. V2, 2006. Available at: www.nccn.org. Accessed September 20, 2009.
24. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer. V1, 2006. Available at: www.nccn.org. Accessed September 20, 2009
25. Anonymous. The Royal College of Radiologists Clinical Oncology Information Network. Guidelines on the non-surgical management of lung cancer. Clin Oncol (R Coll Radiol) 1999;11:S1-S53.
26. SPSS Statistical Program [Computer Program]. Version 17. Chicago, IL: SPSS Inc, 2008.
27. Vinod SK, Delaney GP, Bauman AE, et al. Lung cancer patterns of care in south western Sydney, Australia. Thorax 2003;58:690-694.
28. Conron M, Phuah S, Steinfort D, et al. Analysis of multidisciplinary lung cancer practice. Int Med J 2007;37:18-25. (Pubitemid 44924402)
29. Leo F, Venissac N, Poudenx M, et al. Multidisciplinary management of lung cancer: how to test its efficacy? J Thorac Oncol 2007;2:69-72. (Pubitemid 47163932)
30. Delaney G, Barton M, Jacob S, et al. A model for decision making for the use of radiotherapy in lung cancer. Lancet Oncol 2003;4:120-128. (Pubitemid 36193172)
31. Jacob S, Hovey E, Vinod S, et al. Estimation of an optimal chemotherapy utilisation rate for lung cancer (Abstract). Eur J Cancer 2007;5S:165.
32. Raby B, Pater J, MacKillop WJ. Does knowledge guide practice? Another look at the management of non-small cell lung cancer. J Clin Oncol 1995;13:1904-1911.
33. van Houtte P, Ball DB, Danhier S, et al. Treatment indications and clinical target volume. In: P van Houtte, J Klastersky, P Rocmans, (Eds.), Progress and Perspectives in the Treatment of Lung Cancer. Berlin: Springer-Verlag,1999. Pp. 225-239.
34. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341:2061-2067 (Pubitemid 30035956)
35. Anonymous. BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax 1998;53:S1-S8.
36. Suemitsu R, Takeo S, Hamatake M, et al. The perioperative complications for elderly patients with lung cancer associated with a pulmonary resection under general anaesthesia. J Thorac Oncol 2009;4:193-197.
37. Bernet F, Brodbeck R, Guenin MO, et al. Age does not influence early and late tumor-related outcome for bronchogenic carcinoma. Ann Tho-rac Surg 2000;69:913-918. (Pubitemid 30184723)
38. Gauden SJ, Tripcony L. The curative treatment by radiation therapy alone of Stage I non-small cell lung cancer in a geriatric population. Lung Cancer 2001;32:71-79. (Pubitemid 32224841)
39. Ludbrook JJS, Truong PT, MacNeil MV, et al. Do age and comorbidity impact treatment allocation and outcomes in limited stage small-cell lung cancer? A community-based population analysis. Int J Radiat Oncol Biol Phys 2003;55:1321-1330.
40. Quon H, Shepherd FA, Payne DG, et al. The influence of age on the delivery, tolerance and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer. Int J Radiat Oncol Biol Phys 1999;43:39-45. (Pubitemid 29065830)
41. Tombolini V, Bonanni A, Donato V, et al. Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer. Anticancer Res 2000;20:4829-4833. (Pubitemid 32127738)
42. Hickish TF, Smith IE, O'Brien ME, et al. Clinical benefit from palliative chemotherapy in non-small-cell lung cancer extends to the elderly and those with poor prognostic factors. Br J Cancer 1998;78:28-33.